(Q45034871)

8 December 2017

title

Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis (English)

1 reference

8 December 2017

Ana García-Martínez

1

1 reference

8 December 2017

José Hernández-Rodríguez

series ordinal

2

1 reference

8 December 2017

Josep M Grau

series ordinal

3

1 reference

8 December 2017

Maria C Cid

series ordinal

4

1 reference

8 December 2017

language of work or name

1 reference

1 August 2004

1 reference

8 December 2017

published in

Arthritis & Rheumatology

1 reference

8 December 2017

volume

51

1 reference

8 December 2017

issue

4

1 reference

8 December 2017

page(s)

674-678

1 reference

Polymyalgia rheumatica and giant-cell arteritis.

8 December 2017

cites work

1 reference

Medium- and large-vessel vasculitis

21 January 2018

1 reference

Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis

21 January 2018

1 reference

Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.

21 January 2018

1 reference

Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras

21 January 2018

1 reference

Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages. Stimulation of scavenger receptor activity

21 January 2018

1 reference

Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis

21 January 2018

1 reference

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

21 January 2018

1 reference

Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

21 January 2018

1 reference

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival

21 January 2018

1 reference

A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis

21 January 2018

1 reference

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

21 January 2018

1 reference

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

21 January 2018

1 reference

Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.

21 January 2018

1 reference

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

21 January 2018

1 reference

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

21 January 2018

1 reference

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide

21 January 2018

1 reference

Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion

21 January 2018

1 reference

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.20541

1 reference

8 December 2017

1 reference